Anti-TAG-72 monoclonal antibody (National Institutes of Health)
N/A
Report date: 2024/01/02 20:03:52
Base Information
Drug NameAnti-TAG-72 monoclonal antibody (National Institutes of Health)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPaladin Labs IncNational Institutes Of HealthQuest Pharmatech Inc
China Registration ClassN/A
Develop Information
Active CompaniesNational Cancer Institute
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A